Drägerwerk stock gains 2.51% to EUR 102.20 before Xetra open
Published on 11/11/2026 at 08:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Drägerwerk Investors Watch Next
- Drägerwerk serves hospitals, industry and emergency services with medical and safety technology.
- Recent coverage highlights stronger orders alongside pressure on quarterly profitability.
- The company is scheduled to hold its Capital Markets Day on Wednesday, November 18, 2026.
Drägerwerk stock traded at EUR 102.20 on Lang & Schwarz at 08:24 CET on Wednesday, November 11, 2026, 2.51 percent above the Xetra close of Tuesday, November 10, at EUR 99.70.
The premarket indication puts the stock clearly above the latest completed Xetra session. The comparison uses the Xetra close rather than the prior Lang & Schwarz quote, keeping the reference within the same euro-denominated German listing.
Drägerwerk develops and sells medical and safety technology for hospitals, industry and public-sector customers, according to aktienanalyse.ai. Its medical technology portfolio includes ventilators, anesthesia workstations and patient monitoring, while safety technology covers areas such as respiratory protection and gas detection.
Orders Meet Margin Pressure
Recent reporting on Drägerwerk points to stronger orders and sales, while quarterly profitability remains under pressure. That combination leaves investors focused on whether demand can translate into more consistent margins across the Medical and Safety Technology businesses.
The next scheduled investor event is the Capital Markets Day on Wednesday, November 18, 2026. The date appears in the weekly market calendar published by Tradegate. Management commentary at that event may give investors a closer view of the group's operating priorities and margin trajectory.
Broader market trading can be followed in the DAX market environment.
